Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
125 participants
INTERVENTIONAL
2004-04-30
2005-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To compare classical Chinese acupuncture, semi-standardized modern acupuncture and non-specific needling by means of a double-blinded repeated measures cross-over design.
Intervention: Within three weeks all patients receive three treatment modalities in a random order in a double-blind study design.
Main outcome measures: Improvement in knee flexibility according to the neutral-zero method, defining a success as improvement by 10 degrees or more.
Secondary parameter: improvement in pain according to the reduced WOMAC score by 50 percent or more.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* knee osteoarthritis grade II or III according to the Kellgren classification.
Exclusion Criteria
* malignant disease
* auto-immune disorders
* surgery including arthroscopy during the past 12 months
* pain medication with steroids
* physical therapy or acupuncture within the last for weeks
* no or a pain medication in continuous dosage
35 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The German Society for Traditional Chinese Medicine (DGTCM)
OTHER
Heidelberg University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Max Karner, MD
Role: PRINCIPAL_INVESTIGATOR
University Heidelberg
Johannes Greten, MD
Role: STUDY_DIRECTOR
German Society of Traditional Chinese Medicine
Oliver Gerlach, MD
Role: STUDY_CHAIR
Shen-Centre for Traditional Chinese Medicine, Erlangen, Germany
Frank Brazkiewicz, MD
Role: STUDY_CHAIR
Centre for Chinese Medicine, Bremen, Germany
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AKOK1
Identifier Type: -
Identifier Source: org_study_id